Built on the regulations that protect patients

Our name comes from Title 21 of the Code of Federal Regulations, and it reflects a commitment that has guided us since 2001: patient safety, regulatory compliance, and operational excellence.

As the field evolved, so did we. Title21 grew beyond compliance to serve cellular therapy labs, blood and marrow transplant programs, and biotherapeutic manufacturers, while holding to the same mission: simplify complex processes, improve quality, and enable vital work.

Today, we connect the full advanced therapy workflow, bringing quality, manufacturing, clinical, and operational planning into one digital suite that reduces risk, raises efficiency, and speeds therapies to patients.

Where our name comes from
Title21

Code of Federal Regulations, Food and Drugs

  • Patient safety
  • Regulatory compliance
  • Operational excellence

The commitments behind our name, since 2001.


Two decades of growth, one direction

From quality management to a connected suite for advanced therapies, each step has brought us closer to the work our customers do every day.

  1. 2001

    Founded

    Title21 starts with a focus on quality management in FDA-regulated health sciences.

  2. Growth

    Into cell therapy

    The company expands to serve cellular therapy labs, blood and marrow transplant programs, and biotherapeutic manufacturers.

  3. 2026

    MyCellHub

    Acquiring MyCellHub adds a manufacturing execution system for advanced therapies, with real-time production monitoring and digital batch records.

  4. 2026

    cResults

    Acquiring cResults adds two decades of quality operations planning and scheduling, plus regulatory intelligence and AI-powered document review.

  5. Today

    One digital suite

    Quality, manufacturing, clinical, and operational planning come together to speed the delivery of therapies to patients.


Our Mission

Biotherapies are the future of medicine. We design software that links clinical practice, laboratory science, and therapeutic manufacturing, so our customers can serve patients with quality, efficiency, and kindness.

The industry needs higher quality and better access to tools and data to find and deliver cures. We take pride in supporting our customers’ workflows and in collecting and presenting the data they need to share their stories and care for their patients.

100+

Healthcare sites

12+ years

Of cell therapy expertise

2001

Founded in quality management for FDA-regulated health sciences


Two solutions. One record from start to finish.

GxP Solutions run the regulated work of collecting, manufacturing, and releasing a therapy. Business Solutions plan the lab and quality work around it. Compliant AI works across both, from batch record review to regulatory risk.


Our leadership

The team guiding Title21’s product, technology, clinical, and people strategy.


Join our team of innovators

We are a community of problem-solvers and collaborators bringing innovative software to patients worldwide. If you want to use your talents to make a real impact, explore our open positions and find a career where your contributions matter.

North America

2325 E. Camelback Rd., Suite 320
Phoenix, AZ 85016, USA
866.848.5321

Europe

Kempische Steenweg 303/200
3500 Hasselt, Belgium
VAT BE 0729.548.579

Help us shape what comes next.

Whether you are delivering therapies today or scaling for tomorrow,
we would like to hear what your teams need.